View Cart  

Avanir Sues Impax Over Nuedexta Patent Infringement

A A
Avanir Pharmaceuticals is initiating a second lawsuit against Impax Laboratories, alleging Impax’s ANDA for generic Nuedexta infringes on a new Avanir patent.

To View This Article:

Login

Subscribe To Drug Industry Daily